Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi

Vaccine

Volumn 25, Issue 19, 2007, Pages 3855-3858

  Basso, Beatriz ^a   Castro, Irma ^a   Introini, Virginia ^b   Gil, Patricia ^b   Truyens, Carine ^c   Moretti, Edgardo ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Servicio Nacional de Chagas   (Argentina)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Chagas' disease; Domestic reservoirs; Trypanosoma cruzi; Trypanosoma rangeli; Vaccination

Indexed keywords

PROTOZOON ANTIBODY; TRYPANOSOMA RANGELI VACCINE; TRYPANOSOMA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DOG DISEASE; DRUG EFFICACY; DRUG MECHANISM; EPIMASTIGOTE; INFECTION RATE; NONHUMAN; PARASITE TRANSMISSION; PARASITEMIA; PRIORITY JOURNAL; TRIATOMA INFESTANS; TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; VACCINATION;

EID: 34247109049     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.114     Document Type: Article

References (25)

1. WHO Expert Committee. Control of Chagas disease. World Health Organ Techn Rep Serv 905 (2002) 1-109
2. Garg N., and Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70 10 (2002) 5547-5555
3. Planelles L., Thomas M.C., Alonso C., and Lopez M.C. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 69 10 (2001) 6558-6563
4. Wrightsman R.A., and Manning J.E. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi. Vaccine 18 14 (2000) 1419-1427
5. Araujo Z., El Bouhdidi A., Heremans H., Van Marck E., Castes M., and Carlier Y. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response. Vaccine 17 7/8 (1999) 957-964
6. Costa F., Franchin G., Pereira-Chioccola V.L., Ribeirao M., Schenkman S., and Rodrigues M.M. Immunization with a plasmid DNA containing the gene of transialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16 8 (1998) 768-774
7. Taibi A., Espinoza A.G., and Ouaissi A. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease. Immunol Lett 48 3 (1995) 193-200
8. Stevens J.R., Teixeira M.M., Bingle L.E., and Gibson W.C. The taxonomic position and evolutionary relationships of Trypanosoma rangeli. Int J Parasitol 29 5 (1999) 749-757
9. Basso B., Moretti E.R., and Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am J Trop Med Hyg 44 4 (1991) 413-419
10. Introini M.V., Basso B., and Moretti E.R. Experimental Chagas disease. I. Study of different immunization conditions in the infection course. Bol Chil Parasitol 53 3/4 (1998) 45-51
11. Cervetta L., Moretti E.R., and Basso B. Experimental Chagas' disease: the protection induced by immunization with Trypanosoma rangeli is associated with down-regulation of IL-6, TNFa and IL-10 synthesis. Acta Parasitol 47 1 (2002) 73-78
12. Basso B., Cervetta L., Moretti E., Carlier Y., and Truyens C. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Vaccine 22 (2004) 1868-1872
13. Basso B., Moretti E.R., and Dominguez M. Culture of Trypanosoma cruzi in a monophasic medium with aeration to obtain antigens. Medicina (Buenos Aires) 40 4 (1980) 428-432
14. Pizzi T. La inmunología de la enfermedad de Chagas (1957), Universidad de Chile, Santiago de Chile
15. Guhl F., and Vallejo G.A. Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an update review. Mem Inst Oswaldo Cruz 98 (2003) 435-442
16. Zuniga C.A., Palau T., Penin P., Gramallo C., and de Diego J. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Trop Med Int Health 2 (1997) 482-487
17. Palau M.T., Mejia A.J., Vergara U., and Zuniga C.A. Action of Tripanosoma rangeli in infections with virulent Tripanosoma cruzi populations. Mem Inst Oswaldo Cruz 98 (2003) 543-548
18. Basso B., Moretti E., and Vottero-Cima E. Antigenic relationships between Trypanosoma cruzi and Trypanosoma rangeli. Rev Iber Parasitol 47 (1987) 15-21
19. Reed S.G. Immunology of Trypanosoma cruzi infections. Chem Immunol 70 (1998) 124-143
20. Andrade Z.A., and Andrade S.G. Patología. In: Brener Z., and Andrade Z.A. (Eds). Trypanosoma cruzi e Doença de Chagas (1979), Guanabara Koogan SA, Rio de Janeiro 199-248
21. Basombrio M.A., Segura M.A., Mora M.C., and Gomez L. Field trial of vaccination against American trypanosomiasis (Chagas' disease) in dogs. Am J Trop Med Hyg 49 (1993) 143-151
22. Mazza S, Basso G, Basso R. Primer caso agudo y primeros animales domésticos (perro, gato) infectados con Schizotrypanum cruzi comprobados en la Provincia de Mendoza, Argentina. MEPRA 24; 1935.
23. Gurtler R.E., Cecere M.C., Rubel D.N., Petersen R.M., Schweigmann N.J., and Lauricella M.A. Chagas disease in north-west Argentina: infected dogs as a risk factor for the domestic transmisión of Tripanosoma cruzi. Trans R Soc Trop Med Hyg 85 (1991) 741-745
24. Gurtler R.E., Cohen J.E., Cecere M.C., Lauricella M.A., Chuit R., Segura E.L., et al. Influence of humans and domestic animals on the household prevalence of Tripanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am J Trop Med Hyg 58 (1998) 748-758
25. Reithinger R., Ceballos L., Stariolo R., Davies C.R., and Gurtler R.E. Chagas disease control: deltametrhin-trated collars reduce Triatoma infestans feeding success on dogs. Trans R Soc Trop Med Hyg 99 (2005) 502-508